Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.723066
Abstract: Urothelial cancer (UC) is one of the common refractory tumors and chemotherapy is the primary treatment for it. The advent of immune checkpoint inhibitors (ICI) has facilitated the development of treatment strategies for UC patients.… read more here.
Keywords: gms; glycogen metabolism; treatment; gms patients ... See more keywords